Lundbeck upgrades annual earnings guidance, cuts revenue outlook

Revenue will end up in the lower end of the spread Lundbeck forecast in early 2021, the Danish pharmaceutical firm informs after closing the first two quarters of this year.

Photo: Jens Dresling

After making it through the first half of 2021, Lundbeck adjusts its annual financial guidance, which was set rather wide in the beginning of the year. Now the group makes both upward and downward adjustments.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs